Literature DB >> 30868183

Comparison of outcomes in totally tubeless percutaneous nephrolithotomy according to nephrostomy tract sealing with fibrin versus gelatin matrix: a propensity score matching study.

Jung Jun Kim1, Yoon Seok Suh2, Deok Hyun Han3.   

Abstract

To investigate and compare surgical outcomes in totally tubeless percutaneous nephrolithotomy (ttPCNL) patients according to the type of sealant during nephrostomy tract closure, the records of 158 patients who underwent ttPCNL were retrospectively reviewed. Fibrin sealant [Tisseel®; n = 107, fibrin-only sealant (FS)] or gelatin matrix hemostatic sealant [FloSeal®; n = 51, gelatin matrix sealant (GS)] was applied during tract closure according to surgeon's preference. On the first postoperative day, computed tomography (CT) was scanned for all patients. Unsatisfactory radiological outcome (URO) was defined as any postoperative hematoma or urinoma (≥ 2 cm) on the CT. Unsatisfactory clinical outcome (UCO) was defined as any adverse event requiring additional intervention. Both UROs and UCOs were sub-classified as either hemorrhage or drainage related. 2:1 propensity score matching was applied according to clinical parameters. Median age was 58 (19-78) years and a mean stone size was 2.1 ± 1.1 cm. The treatment success rate (stone free or < 4 mm residual) among all patients was 91.1% (144/158). UROs and UCOs occurred in 35.4% (86/158) and 11.4% (18/158) of all cases, respectively. Neither of the frequency of URO nor hemorrhage-related UCO was different according to sealant type. However, drainage-related UCOs were more prevalent among the GS group, mainly due to the higher postoperative ureter stenting rate. The postoperative pain severity and the length of hospitalization were comparable between groups. In summary, using GS rather than FS during tract closure did not worsen hemorrhage-related outcomes. However, the clinical risk of ureter occlusion requiring additional temporary ureteral stenting was increased.

Entities:  

Keywords:  Percutaneous nephrolithotomy; Sealant; Tract closure; Tubeless

Mesh:

Substances:

Year:  2019        PMID: 30868183     DOI: 10.1007/s00240-019-01126-0

Source DB:  PubMed          Journal:  Urolithiasis        ISSN: 2194-7228            Impact factor:   3.436


  20 in total

1.  Prospective randomized trial of three different methods of nephrostomy tract closure after percutaneous nephrolithotripsy.

Authors:  Roger Li; Michael K Louie; Hak J Lee; Kathryn Osann; Donald L Pick; Rosanne Santos; Elspeth M McDougall; Ralph V Clayman
Journal:  BJU Int       Date:  2010-10-25       Impact factor: 5.588

2.  A randomized comparison of totally tubeless and standard percutaneous nephrolithotomy in elderly patients.

Authors:  Cengiz Kara; Berkan Resorlu; Mirze Bayindir; Ali Unsal
Journal:  Urology       Date:  2010-03-17       Impact factor: 2.649

3.  Totally tubeless percutaneous nephrolithotomy: a prospective randomized controlled study.

Authors:  Chien-Hsing Chang; Chung-Jing Wang; Shi-Wei Huang
Journal:  Urol Res       Date:  2011-02-18

Review 4.  The management of the access tract after percutaneous nephrolithotomy.

Authors:  Tanja Hüsch; Michael Reiter; René Mager; Eva Steiner; Thomas R W Herrmann; Axel Haferkamp; David Schilling
Journal:  World J Urol       Date:  2015-04-23       Impact factor: 4.226

Review 5.  Hemostatic agents used for nephrostomy tract closure after tubeless PCNL: a systematic review and meta-analysis.

Authors:  Cui Yu; Zhou Xu; Wang Long; Liu Longfei; Zeng Feng; Qi Lin; Zu Xiongbing; Chen Hequn
Journal:  Urolithiasis       Date:  2014-07-27       Impact factor: 3.436

6.  What happens to hemostatic agents in contact with urine? An in vitro study.

Authors:  Carlos A Uribe; Louis Eichel; Sepehr Khonsari; David S Finley; Jay Basillote; Hyung Keun Park; Ching Chia Li; Corollos Abdelshehid; David I Lee; Elspeth M McDougall; Ralph V Clayman
Journal:  J Endourol       Date:  2005-04       Impact factor: 2.942

7.  Totally tubeless percutaneous nephrolithotomy for upper pole renal stone using subcostal access.

Authors:  Seyyed Mohammad Kazem Aghamir; Seyed Saeed Modaresi; Mehdi Aloosh; Ali Tajik
Journal:  J Endourol       Date:  2011-03-07       Impact factor: 2.942

8.  Does sealing of the tract with absorbable gelatin (Spongostan) facilitate tubeless PCNL? A prospective study.

Authors:  Iqbal Singh; Ram N Saran; Manish Jain
Journal:  J Endourol       Date:  2008-11       Impact factor: 2.942

9.  A randomized controlled trial of nephrostomy placement versus tubeless percutaneous nephrolithotomy.

Authors:  T J Crook; C R Lockyer; S R Keoghane; B H Walmsley
Journal:  J Urol       Date:  2008-06-12       Impact factor: 7.450

10.  Effectiveness of totally tubeless percutaneous nephrolithotomy in selected patients: a prospective randomized study.

Authors:  Mustafa Okan Istanbulluoglu; Bulent Ozturk; Murat Gonen; Tufan Cicek; Hakan Ozkardes
Journal:  Int Urol Nephrol       Date:  2009-01-23       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.